| Returns | 1W : 3.4% , 1M : -6.2%,1Y : 3.2% |
| Peers & Returns | 1W | 1M | 1Y |
| ALKEM LABORATORIES LTD | 3.4% | -6.2% | 3.2% |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 0% | 3% | 58.9% |
| DR REDDYS LABORATORIES LTD | -0.8% | -3.2% | 43.9% |
| DIVIS LABORATORIES LTD | 0.4% | 2.7% | 57.2% |
| CIPLA LTD | -0.2% | -4.4% | 86.2% |
| BIOCON LTD | 2.6% | 6.3% | 30.6% |
| AUROBINDO PHARMA LTD | 2% | -3.6% | 67.6% |
| LUPIN LTD | 1.2% | 1.5% | 52.2% |
| TORRENT PHARMACEUTICALS LTD | 0.5% | -6.4% | 8% |
| Ratio | Value |
|---|---|
|
P/E P/B P/S |
30.87
P/E Calculated based on EPS of 94.28
[ Mar2020 - Consolidated Results ] 5.65
P/B Calculated based on Book Value of 515.21
[ Mar2020 - Consolidated Results ] 4.1
P/S Calculated based on Revenues of 8498.35 Cr
[ TTM - Consolidated Results ] |
| Model | Discount(-)/ Premium(+) |
|---|---|
|
EV/EBIDTA EV/Sales Price/Sales |
96% 18% 23% |
| Pledged Shares |
0 % |
|---|---|
| As on : Sep2020 | |
If less than 25% | Good |
| If between 25% and 50% | Neutral |
| If greater than 50% | Bad |
